Process Development of Drugs Repurposed for COVID-19
Implementing Organization
National Institute for Interdisciplinary Science and Technology (NIIST)
About
Process developed for Nitazoxanide, EIDD 1931 & EIDD 2801. Non-infringing routes developed for the APIs. Nitazoxanide is currently under clinical trials in Mexico. EIDD 2801 is currently under clinical trials in USA & UK.
National Institute for Interdisciplinary Science and Technology (NIIST)
Acces sibility Controls